Tuoxin Pharmaceutical Group Co.,Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Tuoxin Pharmaceutical Group Co., Ltd. (hereinafter referred to as the company) is a high-tech enterprise that integrates the research and development, production, and sales of chemical synthesis and biological fermentation nucleoside (acid) pharmaceutical intermediates. It has strong strength in the research and production of nucleoside (acid) pharmaceutical intermediates in China. The company has advantages in the research and development of nucleoside (acid) pharmaceutical intermediates in China, such as early start, large scale, and comprehensive variety, and has formed a relatively complete stepped product chain from basic products to high-end products. The company has established an efficient catalytic synthesis reaction technology platform, a nucleoside fermentation technology platform, and a biological conversion semi synthesis technology platform; And multiple series of nucleoside (acid) products have been formed, including pyrimidine series, purine series, nucleotide series, nucleoside series, and other pharmaceutical intermediates such as cytosine, 5-fluorocytosine, and cytidine. In terms of production management, the company has passed the ISO9001 quality management system certification, achieving full process control from product design and development, raw material procurement, process control to product sales. The company actively conducts domestic and international certification and registration work for various products, and multiple pharmaceutical intermediate products have passed official certifications in countries and regions such as Japan and the European Union, such as the EU REACH registration certificate, HALAL halal certification, and KOSHER clean food certification. The company always focuses on "R&D innovation" and attaches great importance to investment in product research and development and the improvement of its comprehensive R&D strength. The company has established the "Henan Province Postdoctoral Research and Development Base" and "National Postdoctoral Research Workstation", and has been recognized as the "National High tech Industry Demonstration Project", "One of the First Backbone Enterprises of Henan Province High tech Characteristic Industry Base", "Henan Province Enterprise Technology Center", "Henan Province Nucleoside Engineering Technology Research Center", and has won the first prize for scientific and technological progress in Henan Province Major scientific and technological awards such as the Second Prize of the National Science and Technology Progress Award, and multiple products have been selected as "National Key New Products" and "National Torch Plan Projects". |
| Headquarter | Xinxiang |
| Establish Date | 2/3/2005 |
| Listed Code | 301089.SZ |
| Listed Date | 10/27/2021 |
| Chairman | Yang Xining. |
| CEO | Cai Yuying. |
| Website | www.tuoxinpharm.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
